Reply to Trudeau, M.; Fraser, B. The CADTH pCODR Expert Review Committee Process Explained. Comment on 'Rayson et al. Access to Neoadjuvant Pertuzumab for HER2 Positive Breast Cancer in Canada: A Dilemma Increasingly Difficult to Explain. Curr. Oncol. 2022, 29, 9891–9895'
- Resource Type
- article
- Authors
- Daniel Rayson; Sonal Gandhi; Anil A. Joy; Christine Brezden-Masley; Karen A. Gelmon; Sandeep Sehdev; David Cescon; Stephen Chia
- Source
- Current Oncology, Vol 30, Iss 5, Pp 5050-5053 (2023)
- Subject
- n/a
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
- Language
- English
- ISSN
- 1718-7729
1198-0052
We appreciate the opportunity to respond to the comment [...]